2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow DWP14012 40mg: new trials by email Literature Review of DWP14012 40mg trials Research Report on DWP14012 40mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori DWP14012 40mg, DWC202301 30mg, Amoxicillin 1000mg - Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 461 | 2024-02-06 | 2025-12-08 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) DWP14012 20mg, DWP14012 40mg, Placebo - Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 324 | 2023-08-31 | 2023-11-08 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) DWP14012 40mg, DWP14012 40mg placebo, Esomeprazole 40mg - Erosive Esophagitis | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 263 | 2018-12-13 | 2020-09-03 |
Non-Erosive Reflux Disease (1)
Daewoong Pharmaceutical Co. LTD. (3)
South Korea (3)